Cambridge Innovation Capital
Venture capital firm based in Cambridge, UK
Cambridge Innovation Capital Investments
Cambridge Innovation Capital has invested in these startups.
T-Therapeutics
Cambridge biotech firm, T-Therapeutics, secures $48M in Series A funding to advance their groundbreaking research on T cell receptor therapeutics, potentially changing the game for cancer and autoimmune treatments. Read more
Secondmind
Cambridge-based software-defined vehicle company Secondmind secures $16M in funding, with notable backers including Mazda, to scale its operations and accelerate the development of its cloud-native optimization engine, aiming to revolutionize the automotive industry with AI-powered technologies. Read more
Riverlane
Riverlane scores a game-changing $75 million Series C funding to revolutionize quantum computing and tackle errors head-on, aiming for a future where one million operations run error-free by 2026! Read more
Nuclera
Nuclera secures $75 million in Series C funding to revolutionize protein production and streamline drug discovery, setting the stage for a biotech breakthrough! Read more
Epitopea
Epitopea secures a £500K grant to revolutionize cancer treatment with cutting-edge immunotherapies targeting hidden antigens—ushering in a new era in the fight against cancer! Read more
Investments By Sector
Cambridge Innovation Capital has invested in these sectors
| Healthtech | 33.3% |
| Hardware | 33.3% |
| Biotech | 25.0% |
| Greentech | 8.3% |
